appendiceal neoplasm
appendiceal neoplasm
Explore linked clinical trials. Standard reference: MONDO:000123629 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies | Abdominal Neoplasms, Adnexal Diseases, Appendiceal Cancer, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Necrosis, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, Urogenital Diseases, Urogenital Neoplasms, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal mesothelioma, peritoneal neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-10-08 | NCT04847063 | |
| Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, appendiceal neoplasm, appendix carcinoma, carcinoma of esophagus, carcinoma of the ampulla of vater, cecal disorder, cecal neoplasm, colon carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system cancer, digestive system disorder, digestive system neoplasm, esophageal disorder, gastric carcinoma, gastric neoplasm, intestinal disorder, neoplasm, rectal carcinoma, rectal disorder, rectal neoplasm, small intestine carcinoma, stomach disorder | Recruiting | Not applicable | 2026-10-02 | NCT07283939 | |
| ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2026-10-02 | NCT01815359 | |
| Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2026-09-25 | NCT07271355 | |
| Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors | Adnexal Diseases, Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, appendiceal neoplasm, bronchial disorder, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cecal disorder, cecal neoplasm, colonic disorder, colonic neoplasm, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm, rectal disorder, rectal neoplasm, respiratory system disorder, respiratory tract neoplasm, stomach disorder, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT06128551 | |
| Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Peritoneal Diseases, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, peritoneal neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-09-16 | NCT07487168 | |
| EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. | Anal Cancer, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, anus disorder, anus neoplasm, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, intestinal disorder, liver cancer, liver disorder, malignant colon neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, rectal cancer, rectal disorder, rectal neoplasm, stomach disorder | Recruiting | Not applicable | 2026-09-15 | NCT06263088 | |
| PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer | Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, Urogenital Diseases, Urogenital Neoplasms, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, intestinal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal neoplasm, rectal disorder, stomach disorder, uterine cancer, uterine disorder | Recruiting | Phase 1 | 2026-08-26 | NCT04329494 | |
| The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei | Recruiting | Not stated | 2026-08-17 | NCT07769346 | |
| A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colorectal adenocarcinoma, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Not applicable | 2026-07-21 | NCT07291180 | |
| Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | Abdominal Neoplasms, Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, bile duct cancer, bile duct disorder, bile duct neoplasm, biliary tract disorder, carcinoma, cecal disorder, cecal neoplasm, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, peritoneal neoplasm, rectal disorder, stomach disorder | Active, not recruiting | Phase 1 | 2026-07-13 | NCT05277766 | |
| Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) | Appendiceal Cancer, Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Extrahepatic Cholangiocarcinoma, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, biliary tract disorder, carcinoma, cecal disorder, cecal neoplasm, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, intestinal disorder, intrahepatic cholangiocarcinoma, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-07-02 | NCT06101277 | |
| Molecular Profiling for Risk Stratification in Appendiceal Cancer | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, appendix adenocarcinoma, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm | Recruiting | Not stated | 2026-06-29 | NCT07587268 | |
| Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-06-22 | NCT05780684 | |
| Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Active, not recruiting | Not applicable | 2026-06-15 | NCT01946854 | |
| Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors | Adnexal Diseases, Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, appendiceal neoplasm, bronchial disorder, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cecal disorder, cecal neoplasm, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm, rectal disorder, rectal neoplasm, respiratory system disorder, respiratory tract neoplasm, stomach disorder, uterine disorder | Active, not recruiting | Phase 1 | 2026-05-15 | NCT05462717 | |
| Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Peritoneal Diseases, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, peritoneal neoplasm | Recruiting | Phase 2 | 2026-05-14 | NCT05913674 | |
| Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, carcinoma, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei, rectal disorder | Recruiting | Phase 2 | 2026-04-01 | NCT04779554 | |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-16 | NCT05194995 | |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | Anal Cancer, Biliary Tract Neoplasms, Cancer Pain, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Neurologic Manifestations, Nociceptive Pain, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Signs and Symptoms, Visceral Pain, adenocarcinoma, anus disorder, anus neoplasm, appendiceal neoplasm, bile duct cancer, bile duct disorder, bile duct neoplasm, biliary tract cancer, biliary tract disorder, carcinoid tumor, carcinoma, cecal disorder, cecal neoplasm, cecum neuroendocrine tumor G1, colon neuroendocrine tumor G1, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, enterochromaffin cell serotonin-producing pancreatic neuroendocrine tumor, epithelial neoplasm, esophageal cancer, esophageal disorder, gallbladder disorder, gallbladder neoplasm, gastric cancer, gastric neoplasm, ileal neuroendocrine tumor G1, intestinal disorder, liver cancer, liver disorder, malignant colon neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, peritoneum cancer, primitive neuroectodermal tumor, rectal cancer, rectal disorder, rectal neoplasm, rectal neuroendocrine tumor G1, small intestinal neuroendocrine tumor G1, small intestine cancer, stomach disorder | Recruiting | Not applicable | 2026-02-20 | NCT04907643 | |
| Target-specific immunoPET Imaging of Digestive System Carcinoma | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Site, Simpson-Golabi-Behmel syndrome, appendiceal neoplasm, bile duct carcinoma, bile duct disorder, bile duct neoplasm, biliary tract disorder, cancer, cecal disorder, cecal neoplasm, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system cancer, digestive system carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, esophageal cancer, esophageal disorder, gallbladder carcinoma, gallbladder disorder, gallbladder neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, liver cancer, liver disorder, malignant colon neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal cancer, rectal disorder, rectal neoplasm, small intestine cancer, stomach disorder | Recruiting | Not applicable | 2025-12-31 | NCT06715839 | |
| Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, appendiceal neoplasm, appendix carcinoma, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, small intestine adenocarcinoma | Recruiting | Phase 2 | 2025-12-17 | NCT05472948 | |
| Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Not stated | 2025-12-03 | NCT04157322 | |
| Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) | Appendiceal Cancer, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, intestinal disorder, neoplasm, stomach disorder | Recruiting | Phase 4 | 2025-09-15 | NCT07124351 | |
| Genetics of Appendix Cancer Study | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, appendix adenocarcinoma, appendix neuroendocrine tumor G1, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade | Recruiting | Not stated | 2025-04-18 | NCT05734430 |